the goal of this trial is to match the effects of nivolumab with chemo- immunotherapy on people diagnosed with Principal Mediastinal B-cell lymphoma (PMBCL), an aggressive form of enormous B-cell lymphoma. procedure for https://dirstop.com/story20369396/top-find-a-clinical-trial-secrets